Mirae Asset Global Etfs Holdings Ltd. Tango Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,522 shares of TNGX stock, worth $86,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,522Holding current value
$86,264% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
121Shares Held
86.8MCall Options Held
2.6KPut Options Held
1K-
Trv Gp Iv, LLC Boston, MA16.9MShares$57 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$45.1 Million4.04% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$27.7 Million3.91% of portfolio
-
Nextech Invest Ag5.53MShares$18.7 Million8.96% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$17.8 Million1.32% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $298M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...